Acetamide, N-(2,4-dinitrophenyl)-, reaction products with 1-methyl-2,4-dinitrobenzene and sodium sulfide (Na2(Sx)), leuco derivatives

Skin sensitisation

Administrative data

Endpoint:

skin sensitisation: in vivo (LLNA)

Type of information:

experimental study

Adequacy of study:

key study

Study period:

29 August 2017 - 09 November 2017

Reliability:

1 (reliable without restriction)

Rationale for reliability incl. deficiencies:

guideline study

Data source

Reference

Reference Type:

study report

Title:

Unnamed

Year:

2017

Report date:

2017

Materials and methods

Test guideline

Test guideline 1

Qualifier:

according to guideline

Guideline:

OECD Guideline 429 (Skin Sensitisation: Local Lymph Node Assay)

Version / remarks:

22 July 2010

Deviations:

no

Test guideline 2

Qualifier:

according to guideline

Guideline:

EU Method B.42 (Skin Sensitisation: Local Lymph Node Assay)

Version / remarks:

20 July 2012

Deviations:

no

GLP compliance:

yes (incl. QA statement)

Type of study:

mouse local lymph node assay (LLNA)

Test material

Test material information

Constituent 1

Reference substance name:

Acetamide, N-(2,4-dinitrophenyl)-, reaction products with 1-methyl-2,4-dinitrobenzene and sodium sulfide (Na2(Sx)), leuco derivatives

EC Number:

288-896-1

EC Name:

Acetamide, N-(2,4-dinitrophenyl)-, reaction products with 1-methyl-2,4-dinitrobenzene and sodium sulfide (Na2(Sx)), leuco derivatives

Cas Number:

85940-08-5

Molecular formula:

not applicable

IUPAC Name:

Reaction product of N-(2,4-dinitrophenyl)acetamide with 1-methyl-2,4-dinitrobenzene and polysulfide, leuco derivatives

Test material form:

solid: particulate/powder

Details on test material:

Test item: Leuco Sulphur Brown 46
Appearance: Brown powder
CAS No: 85940-08-5

In vivo test system

Test animals

Species:

mouse

Strain:

CBA/Ca

Remarks:

CBA/Ca Ola Hsd mice

Sex:

female

Details on test animals and environmental conditions:

Source: TOXI-COOP ZRT., H-1103, Budapest, Cserkesz u. 90.
Hygienic level at arrival: SPF
Hygienic level duringthe study: Good conventional
Justification of strain: On the basis of comparative investigations in other laboratories, mice of the CBA/Ca strain were found to exhibit a more marked response than other strains. Females are used because the existing database is predominantly based on females.
Number of animals: 28 animals/main test* (4 animals/treatment group, 12 shared control animals)
Sex: Female, nulliparous, non-pregnant
Age of animals: Young adult mice; 12 weeks old (at start of the main test)
Body weight range at starting: 17.8 – 22.4 g. The weight variation in animals involved in the study did not exceed +/- 20 % of the mean weight.
Acclimatization time: 12 days

Husbandry
Animal health: Only healthy animals (and not showing any sign of skin lesion) were used
Housing duringacclimatization period: Grouped caging in small groups
Housing during the test: Grouped caging (4 animals/cage)
Cage type: Type II. Polypropylene / polycarbonate
Bedding: Laboratory bedding
Light: 12 hours daily, from 6.00 a.m. to 6.00 p.m.
Temperature: 22 ± 3 °C
Relative humidity: 30 – 70 %
Housing/Enrichment: Mice were group-housed to allow social interaction, and with deep wood sawdust bedding, to allow digging and other normal
rodent activities.

The same conditions were used for the dose range finding and main test animals. There were no deviations from these specifications during the experimental phase. The temperature and relative humidity were recorded daily during the acclimatization and experimental phases. Before housing the animals, the
microbiological status of the room was checked.

Food and Water Supply

Animals received ssniff® Rat/Souris-Elevage E complete diet for rats and mice produced by ssniff Spezialdiäten GmbH, D-59494 Soest Germany, ad libitum.
The food is periodically analysed and is considered not to contain any contaminants that could reasonably be expected to affect the purpose or integrity of
the study. Copies of the relevant Certificates of Analysis are maintained in TOXI-COOP ZRT.’s archive. Relevant batch number, expiry date and contents of
the diet are given in Appendix III. 
Animals received tap water from watering bottles ad libitum. The drinking water is periodically analysed and is considered not to contain any contaminants
that could reasonably be expected to affect the purpose or integrity of the study. Copies of the relevant Certificates of Analysis are maintained in
TOXI-COOP ZRT.’s archive.

Identification of Animals

The individual identification of the animals was performed by numbers on the tail. The cages were marked with identification cards, with information (at least) about study code, species, strain, sex, dose group and individual animal numbers.

Study design: in vivo (LLNA)

Vehicle:

dimethyl sulphoxide

Concentration:

1.56, 3.13, 6.25 and 12.5 % (w/w)

No. of animals per dose:

4 animals/treatment group

Details on study design:

Animals in the treatment groups were treated with the negative controls (vehicles), appropriate formulations of the test item or 25 % (w/v) concentration of the positive control substance. The test item was administered at four different concentrations according to the results of the dose range finding test.

Each mouse was topically treated with 25 µL of the appropriate formulations of the test item, the positive control substance or the vehicles using a pipette, on the dorsal surface of each ear. After the treatments animals were returned to their cages. Each animal was dosed once a day for three consecutive days
(Days 1, 2 and 3). There was no treatment on Days 4, 5 and 6.

No animals showed symptoms of systemic toxicity or excessive skin irritation, and no technical treatment failures were observed during the test. All animals treated were processed and therefore no treatment group was excluded from the evaluation.

Injection of 3HTdR
On Day 6 each mouse was intravenously injected via the tail vein with 250 µL of sterile PBS (1 x PBS, diluted from 10x concentrate) containing approximately 20 µCi of 3H-methyl-thymidine using a hypodermic needle with 1 mL sterile syringe. Once injected, mice were left for 5 hours (± 30 minutes).

Five hours (± 30 minutes) after intravenous injection the mice were sacrificed by cervical dislocation. The draining auricular lymph nodes were excised by making a small incision in the skin between the jaw and the sternum, pulling the skin gently back towards the ears and exposing the lymph nodes. Then the nodes were removed using forceps. Once removed, the nodes of the mice from each test group were pooled and collected separately in a Petri dish containing a small amount (1-2 mL) of PBS to keep the nodes wet before processing.

A single cell suspension (SCS) of lymph node cells (LNCs), pooled according to groups, was prepared and collected in disposable tubes by gentle mechanical disaggregating of the lymph nodes through a cell strainer using the plunger of a disposable syringe. The cell strainer was washed with PBS (up to 10 mL). LNCs were pelleted with a relative centrifugal force (RCF) of approximately 190 x g for 10 minutes at 4 °C. After centrifugation, the supernatant was removed, leaving 1-2 mL supernatant above each pellet. The pellets were gently agitated before making up to 10 mL with PBS and re-suspending the LNCs. The washing procedure was repeated twice. This procedure was repeated for each group of pooled lymph nodes.
 
Determination of Incorporated 3HTdR
After the final wash, each supernatant was removed leaving a small volume (< 0.5 mL) of supernatant above each pellet. The pellets were gently agitated before suspending the LNCs in 3 mL of 5 % (w/v) trichloroacetic acid (TCA, dissolved in purified water) for precipitation of the macromolecules. After incubation with 5 % TCA at 2-8 °C overnight (approx. 18 hrs), each precipitate was removed by centrifugation of the samples at approximately 190 x g for 10 minutes at 4 °C and decanting the supernatants, than the pellets were re-suspended in 1 mL of 5 % TCA and dispersed using an ultrasonic water bath. Samples were transferred to suitable sized scintillation vials containing 10 mL of scintillation liquid, gently mixed and loaded into the beta-scintillation counter. 3HTdR incorporation was measured for up to 10 minutes per sample. The beta-counter expressed the 3HTdR incorporation as the amount of radioactive disintegration per minute (DPM). Similarly, background 3HTdR levels were measured in two 1 mL aliquots of 5 % TCA.

Instrument used for the measurement:
Name: Tri-Carb 3100TR Liquid Scintillation Analyzer
Serial Number: 072971

Clinical Observations
During the main test (from Day 1 to Day 6) all animals were observed at least once a day for any clinical signs, including systemic toxicity and local irritation. Irritation was monitored by erythema scoring during the whole test. Individual records were maintained.

Individual body weights were recorded on Day 1 (beginning of the test) and on Day 6 (prior to 3HTdR injection) with a precision of ± 0.1 g.

DPM (disintegration per minute) was measured for each treatment group. The measured DPM values were corrected with the background DPM value. The average of the two measured DPM values of 5 % (w/v) TCA solutions was used as the background DPM value. The results were expressed as DPM/mouse. The stimulation index (SI = the DPM/mouse of a treated (positive control or test item) group divided by the DPM/mouse of the respective negative control group) for each treatment group was also calculated. A stimulation index of 3 or greater is an indication of a positive result. Dose-response relationship was evaluated by linear regression using SI values. All calculations were made by Microsoft Excel Software. Based on the results an EC3 value (dose calculated to induce a stimulation index of 3) was not calculated for the test item. 

The test item is considered as a skin sensitizer, if:
Exposure to at least one concentration of the test item resulted in an incorporation of 3HTdR at least 3-fold or greater than recorded in control mice, as indicated by the stimulation index (SI ≥ 3). However, the strength of the dose-response, the statistical significance and the consistency of the solvent/vehicle and positive control responses may also be used when determining whether a borderline result is declared positive.

Positive control substance(s):

hexyl cinnamic aldehyde (CAS No 101-86-0)

Statistics:

The randomization was checked by computer software [SPSS/PC+ (4.0.1)] .

Results and discussion

Positive control results:

The positive control item (25 % (w/v) HCA in Acetone : Olive oil 4:1 (v/v) mixture, AOO) induced significant stimulation when compared to the
concurrent control (SI = 15.8), thus confirming the validity of the assay.

In vivo (LLNA)

Results

Results 1

Key result

Parameter:

EC3

Remarks on result:

not determinable

Remarks:

SI values were below 3 at all tested concentrations

Results 2

Parameter:

SI

Value:

2.3

Variability:

p = 0.01, r = 0.99

Test group / Remarks:

at test item concentration of 12.5 °%

Results 3

Parameter:

SI

Value:

1.6

Variability:

p = 0.01, r = 0.99

Test group / Remarks:

at test item concentration of 6.25 °%

Results 4

Parameter:

SI

Value:

1

Variability:

p = 0.01, r = 0.99

Test group / Remarks:

at test item concentrations of 3.13 °%

Results 5

Parameter:

SI

Value:

0.7

Variability:

p = 0.01, r = 0.99

Test group / Remarks:

at test item concentration of 1.56 °%

Cellular proliferation data / Observations:

No significantly increased lymphoproliferation (indicated by an SI >= 3) compared to the relevant control [50 % (v/v) DMSO in water] was noted for the test item at the applied test concentrations. The observed stimulation index values were 2.3, 1.6, 1.0 and 0.7 at test item concentrations of 12.5 %, 6.25 %, 3.13 % and 1.56 % (w/w), respectively. The dose-response correlation was statistically significant (p = 0.01, r = 0.99; evaluated by linear regression using SI values). According to evaluation criteria of the relevant guidelines the lack of a significantly increased lymphoproliferation (indicated by an SI >= 3) up to the maximum attainable concentration of 12.5 % (w/w) is considered as evidence that the test item is not a skin sensitizer.
No mortality or signs of systemic toxicity were observed during the test. No significant treatment related effect on the body weights was observed in any dose group. No signs of irritation or any other local effects were observed at the treatment site (ears) in any treatment group.

Any other information on results incl. tables

Individual Body Weights of the Animals with Group Means and the Body Weight Changes in the Dose Range Finding Test

Animal	Dose Group	Initial Body	Terminal Body	Body Weight
Number		Weight (g)	Weight (g)*	Change (%)
435	Leuco Sulphur Brown 46	18.1	18.1	0
436	12.5 % in DMSO : water	20.2	20.4	1
	Mean	19.2	19.3	1
437	Leuco Sulphur Brown 46	17.5	18.0	3
438	6.25 % in DMSO : water	20.2	20.1	0
	Mean	18.9	19.1	1

 *Terminal body weights were measured on Day 6.

 

Clinical Observations in the Dose Range Finding Test

Dose Group	Animal Number	Days
		1		2		3		4	5	6
		PT	AT	PT	AT	PT	AT
Leuco Sulphur Brown 46 12.5 % in DMSO : water	435	N	N	N	N	N	N	N	N	N
	436	N	N	N	N	N	N	N	N	N
Leuco Sulphur Brown 46 6.25 % in DMSO : water	437	N	N	N	N	N	N	N	N	N
	438	N	N	N	N	N	N	N	N	N

T = Treatment

PT = Prior to the treatment

AT = After the treatment

DMSO= Dimethyl sulfoxide

N = Normal (no sign of toxicity observed)

 

Erythema Scores in the Dose Range Finding Test

Dose Group	Animal Number	Ears	Days
			1		2		3		4	5	6
			PT	AT	PT	AT	PT	AT
Leuco Sulphur Brown 46 12.5 % in DMSO : water	435	L	0	0	0	0	0	0	0	0	0
		R	0	0	0	0	0	0	0	0	0
	436	L	0	0	0	0	0	0	0	0	0
		R	0	0	0	0	0	0	0	0	0
Leuco Sulphur Brown 46 6.25 % in DMSO : water	437	L	0	0	0	0	0	0	0	0	0
		R	0	0	0	0	0	0	0	0	0
	438	L	0	0	0	0	0	0	0	0	0
		R	0	0	0	0	0	0	0	0	0

L = Left                                                           R = Right

PT = Prior to the treatment                                AT = After the treatment

DMSO= Dimethyl sulfoxide

 Individual Ear Thickness Values and the Deviations from the Initial Values in the Dose Range Finding Test

Dose Group	Animal	Ears	Day 1^*	Day 3^$	Day 3	Day 6^#	Day 6
	Number		value (mm)	value (mm)	% deviation	value (mm)	% deviation
	435	L	0.20	0.19	-5.0	0.19	-5.0
Leuco Sulphur Brown 46		R	0.20	0.20	0.0	0.19	-5.0
12.5 % in DMSO : water	436	L	0.18	0.19	5.6	0.21	16.7
		R	0.18	0.19	5.6	0.20	11.1
	437	L	0.20	0.19	-5.0	0.19	-5.0
Leuco Sulphur Brown 46		R	0.20	0.20	0.0	0.19	-5.0
6.25 % in DMSO : water	438	L	0.20	0.21	5.0	0.19	-5.0
		R	0.20	0.21	5.0	0.19	-5.0

 L = Left

R = Right

DMSO= Dimethyl sulfoxide

 

* Ear thickness was measured prior to the first treatment.

$ Ear thickness was measured approximately 48 hours after the first treatment (prior to the third treatment).

# Ear thickness was measured at the end of the test.

Individual Body Weights of the Animals with Group Means, the Associated Error Termsand Body Weight Changes in the Main Test

Animal	Dose Group	Initial	Terminal	Body Weight
Number		Body Weight	Body Weight	Change
		(g)	(g)	(%)
455	Vehicle control	21.6	21.8	1
456	for the positive control:	17.9	18.4	3
457	AOO	20.0	20.5	3
458		20.8	20.8	0
	Mean	20.1	20.4	1
	SD	1.6	1.4
459	Positive control:	20.8	20.8	0
460	25 % HCA	17.8	17.6	-1
461	in AOO	21.8	21.6	-1
462		20.0	20.3	2
	Mean	20.1	20.1	0
	SD	1.7	1.7
463	Vehicle control	20.1	19.5	-3
464	for the test item:	21.7	22.6	4
465	50 % DMSO in water	20.8	22.7	9
466		17.9	18.1	1
	Mean	20.1	20.7	3
	SD	1.6	2.3
467	Leuco Sulphur Brown 46	20.7	20.9	1
468	12.5 %	19.9	20.4	3
469	in DMSO : water	21.9	21.3	-3
470		18.1	18.6	3
	Mean	20.2	20.3	1
	SD	1.6	1.2
471	Leuco Sulphur Brown 46	22.3	21.8	-2
472	6.25 %	18.5	17.5	-5
473	in DMSO : water	20.6	20.9	1
474		19.9	17.8	-11
	Mean	20.3	19.5	-4
	SD	1.6	2.2
475	Leuco Sulphur Brown 46	20.7	20.1	-3
476	3.13 %	20.1	20.1	0
477	in DMSO : water	18.6	18.7	1
478		22.2	21.9	-1
	Mean	20.4	20.2	-1
	SD	1.5	1.3
479	Leuco Sulphur Brown 46	20.2	20.4	1
480	1.56 %	20.5	20.8	1
481	in DMSO : water	22.4	23.0	3
482		18.8	18.9	1
	Mean	20.5	20.8	1
	SD	1.5	1.7

HCA =a-Hexylcinnamaldehyde                           AOO = Acetone: Olive oil 4:1 (v/v) mixture

DMSO = Dimethyl sulfoxide                                SD = Standard Deviation

Clinical Observations in the Main Test

Dose Group	Animal Number	Days
		1		2		3		4	5	6
		PT	AT	PT	AT	PT	AT
Vehicle control for the positive control: AOO	455	N	N	N	N	N	N	N	N	N
	456	N	N	N	N	N	N	N	N	N
	457	N	N	N	N	N	N	N	N	N
	458	N	N	N	N	N	N	N	N	N
Positive control: 25 % HCA in AOO	459	N	N	N	N	N	N	N	N	N
	460	N	N	N	N	N	N	N	N	N
	461	N	N	N	N	N	N	N	N	N
	462	N	N	N	N	N	N	N	N	N
Vehicle control for the test item: 50 % DMSO in water	463	N	N	N	N	N	N	N	N	N
	464	N	N	N	N	N	N	N	N	N
	465	N	N	N	N	N	N	N	N	N
	466	N	N	N	N	N	N	N	N	N
Leuco Sulphur Brown 46 12.5 % in DMSO : water	467	N	N	N	N	N	N	N	N	N
	468	N	N	N	N	N	N	N	N	N
	469	N	N	N	N	N	N	N	N	N
	470	N	N	N	N	N	N	N	N	N
Leuco Sulphur Brown 46 6.25 % in DMSO : water	471	N	N	N	N	N	N	N	N	N
	472	N	N	N	N	N	N	N	N	N
	473	N	N	N	N	N	N	N	N	N
	474	N	N	N	N	N	N	N	N	N
Leuco Sulphur Brown 46 3.13 % in DMSO : water	475	N	N	N	N	N	N	N	N	N
	476	N	N	N	N	N	N	N	N	N
	477	N	N	N	N	N	N	N	N	N
	478	N	N	N	N	N	N	N	N	N
Leuco Sulphur Brown 46 1.56 % in DMSO : water	479	N	N	N	N	N	N	N	N	N
	480	N	N	N	N	N	N	N	N	N
	481	N	N	N	N	N	N	N	N	N
	482	N	N	N	N	N	N	N	N	N

 

PT = Prior to the treatment

AT = After the treatment

HCA =a-Hexylcinnamaldehyde

AOO = Acetone: Olive oil 4:1 mixture (v/v)

DMSO = Dimethyl sulfoxide

 

N = Normal (no symptoms observed)

 

Erythema Scores in the Main Test

Dose Group	Animal Number	Ears	Days
			1		2		3		4	5	6
			PT	AT	PT	AT	PT	AT
Vehicle control for the positive control: AOO	455	L	0	0	0	0	0	0	0	0	0
		R	0	0	0	0	0	0	0	0	0
	456	L	0	0	0	0	0	0	0	0	0
		R	0	0	0	0	0	0	0	0	0
	457	L	0	0	0	0	0	0	0	0	0
		R	0	0	0	0	0	0	0	0	0
	458	L	0	0	0	0	0	0	0	0	0
		R	0	0	0	0	0	0	0	0	0
Positive control: 25 % HCA in AOO	459	L	0	0	0	0	0	0	0	0	0
		R	0	0	0	0	0	0	0	0	0
	460	L	0	0	0	0	0	0	0	0	0
		R	0	0	0	0	0	0	0	0	0
	461	L	0	0	0	0	0	0	0	0	0
		R	0	0	0	0	0	0	0	0	0
	462	L	0	0	0	0	0	0	0	0	0
		R	0	0	0	0	0	0	0	0	0
Vehicle control for the test item: 50 % DMSO in water	463	L	0	0	0	0	0	0	0	0	0
		R	0	0	0	0	0	0	0	0	0
	464	L	0	0	0	0	0	0	0	0	0
		R	0	0	0	0	0	0	0	0	0
	465	L	0	0	0	0	0	0	0	0	0
		R	0	0	0	0	0	0	0	0	0
	466	L	0	0	0	0	0	0	0	0	0
		R	0	0	0	0	0	0	0	0	0
Leuco Sulphur Brown 46 12.5 % in DMSO : water	467	L	0	0	0	0	0	0	0	0	0
		R	0	0	0	0	0	0	0	0	0
	468	L	0	0	0	0	0	0	0	0	0
		R	0	0	0	0	0	0	0	0	0
	469	L	0	0	0	0	0	0	0	0	0
		R	0	0	0	0	0	0	0	0	0
	470	L	0	0	0	0	0	0	0	0	0
		R	0	0	0	0	0	0	0	0	0
Leuco Sulphur Brown 46 6.25 % in DMSO : water	471	L	0	0	0	0	0	0	0	0	0
		R	0	0	0	0	0	0	0	0	0
	472	L	0	0	0	0	0	0	0	0	0
		R	0	0	0	0	0	0	0	0	0
	473	L	0	0	0	0	0	0	0	0	0
		R	0	0	0	0	0	0	0	0	0
	474	L	0	0	0	0	0	0	0	0	0
		R	0	0	0	0	0	0	0	0	0
Leuco Sulphur Brown 46 3.13 % in DMSO : water	475	L	0	0	0	0	0	0	0	0	0
		R	0	0	0	0	0	0	0	0	0
	476	L	0	0	0	0	0	0	0	0	0
		R	0	0	0	0	0	0	0	0	0
	477	L	0	0	0	0	0	0	0	0	0
		R	0	0	0	0	0	0	0	0	0
	478	L	0	0	0	0	0	0	0	0	0
		R	0	0	0	0	0	0	0	0	0
Leuco Sulphur Brown 46 1.56 % in DMSO : water	479	L	0	0	0	0	0	0	0	0	0
		R	0	0	0	0	0	0	0	0	0
	480	L	0	0	0	0	0	0	0	0	0
		R	0	0	0	0	0	0	0	0	0
	481	L	0	0	0	0	0	0	0	0	0
		R	0	0	0	0	0	0	0	0	0
	482	L	0	0	0	0	0	0	0	0	0
		R	0	0	0	0	0	0	0	0	0

L = Left                                     R = Right                    PT = Prior to treatment                               AT = After the treatment

AOO = Acetone: Olive oil 4:1 (v/v) mixture                    HCA =a-Hexylcinnamaldehyde                  DMSO = Dimethyl sulfoxide

Visual Observations of the Lymph Nodes in the Main Test

Dose Group	Animal Number	Appearance of Lymph Nodes
Vehicle control for the positive control: AOO	455	N
	456	N
	457	N
	458	N
Positive control: 25 % HCA in AOO	459	Larger than the relevant control (AOO)
	460	Larger than the relevant control (AOO)
	461	Larger than the relevant control (AOO)
	462	Larger than the relevant control (AOO)
Vehicle control for the test item: 50 % DMSO in water	463	N
	464	N
	465	N
	466	N
Leuco Sulphur Brown 46 12.5 % in DMSO : water	467	N
	468	N
	469	N
	470	N
Leuco Sulphur Brown 46 6.25 % in DMSO : water	471	N
	472	N
	473	N
	474	N
Leuco Sulphur Brown 46 3.13 % in DMSO : water	475	N
	476	N
	477	N
	478	N
Leuco Sulphur Brown 46 1.56 % in DMSO : water	479	N
	480	N
	481	N
	482	N

AOO = Acetone: Olive oil 4:1 (v/v) mixture

HCA =a-Hexylcinnamaldehyde

DMSO = Dimethyl sulfoxide

N = Normal

DPM and Stimulation Index Values for all Groups in the Main Test

Dose Group	Measured	Group^*	DPM/Mouse^#	Stimulation
	DPM/group	DPM		Index Values
Vehicle control for the positive control:	3189	3163.5	790.9	1.0
AOO
Positive control:	50042	50016.5	12504.1	15.8
25 % HCA in AOO
Vehicle control for the test item:	2602	2576.5	644.1	1.0
50 % DMSO in water
Leuco Sulphur Brown 46	6067	6041.5	1510.4	2.3
12.5 % in DMSO : water
Leuco Sulphur Brown 46	4209	4183.5	1045.9	1.6
6.25 % in DMSO : water
Leuco Sulphur Brown 46	2663	2637.5	659.4	1.0
3.13 % in DMSO : water
Leuco Sulphur Brown 46	1707	1681.5	420.4	0.7
1.56 % in DMSO : water

 HCA =a-Hexylcinnamaldehyde

AOO = Acetone: Olive oil 4:1 (v/v) mixture

DMSO = Dimethyl sulfoxide

 *Group DPM = measured DPM_group- average DPM_backgroundAverage DPM_background= 25.5

# Number of animals/group = 4

Applicant's summary and conclusion

Interpretation of results:

GHS criteria not met

Conclusions:

The test item was shown to have no skin sensitization potential in the Local Lymph Node Assay.

Executive summary:

The aim of this study was to evaluate the skin sensitization potential of the test following dermal exposure in the Local Lymph Node Assay according to OECD guideline 429. Preliminary tests were performed to find an appropriate vehicle and the maximum applicable concentration. Solubility of the test item was evaluated in N,N-Dimethylformamide (DMF) and Dimethyl sulfoxide (DMSO) at 25 % and 12.5 % (w/w) concentrations (based on previous studies performed for test items with similar chemical characteristics). Limited solubility of the test item has been observed in both vehicles and the formulations were not adequately homogeneous for a proper application. According to the Sponsor’s request the test item was formulated in water resulting in a thick suspension (slurry) at a nominal concentration of 25 % (w/w) prior to dilution with an appropriate vehicle (DMSO) in a ratio of 1:1 (v/v). The 12.5 % (w/w) formulation prepared in this way was an adequately stable and homogeneous suspension for application on the dorsum of ears of animals. No significant adverse effects (systemic toxicity or irritation) were observed in the dose range finding test (12.5 % and 6.25 % (w/w) were tested). According to this the test item was examined in the main test at concentrations of 12.5 % and at 6.25 %, 3.13 % or 1.56 % (w/w; prepared by serial dilution in DMSO : water 1:1 (v/v) mixture) as suspension formulations. An appropriate positive control (a-Hexylcinnamaldehyde, HCA) and furthermore two negative control groups dosed with DMSO : water 1:1 (v/v) mixture(as vehicle control for the test groups) or AOO (as vehicle control for the positive control group) were employed. The positive control item (25 % (w/v) HCA in Acetone : Olive oil 4:1 (v/v) mixture, AOO) induced significant stimulation when compared to the concurrent control (SI = 15.8), thus confirming the validity of the assay. No mortality or signs of systemic toxicity were observed during the test. No significant treatment related effect on the body weights was observed in any dose group. No signs of irritation or any other local effects were observed at the treatment site (ears) in any treatment group. No significantly increased lymphoproliferation (indicated by a SI >= 3) compared to the relevant control [50 % (v/v) DMSO in water] was noted for the test item at the applied test concentrations. The observed stimulation index values were 2.3, 1.6, 1.0 and 0.7 at test item concentrations of 12.5 %, 6.25 %, 3.13 % and 1.56 % (w/w), respectively. The dose-response correlation was statistically significant (p = 0.01, r = 0.99; evaluated by linear regression using SI values). According to evaluation criteria of the relevant guidelines, the lack of a significantly increased lymphoproliferation (indicated by a SI >= 3) up to the maximum attainable concentration of 12.5 % (w/w) is considered as evidence that the test item is not a skin sensitizer. In conclusion, under the conditions of the present assay, the test item tested at the maximum feasible concentration of 12.5 % (w/w) and also at concentrations of 6.25 %, 3.13 % or 1.56 % (w/w) as adequate homogeneous formulations was shown to have no skin sensitization potential in the Local Lymph Node Assay.